Certara (CERT)

• Market cap: $1.8B
• 1 day: -0.62%
• 5 days: 4.28%
• 1 month: 1.72%
• 3 months: 4.18%
• 6 months: 1.54%
• Year to date: 5.16%
• 1 year: 4.77%
• 5 years: -70.56%
• 10 years: -70.56%
• Sector: Healthcare
• Industry: Health Information Services

About: Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Employees: 1,546

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

65% more call options, than puts

Call options by funds: $708K | Put options by funds: $430K

24% more capital invested

Capital invested by funds: $1.21B [Q1] → $1.5B (+$295M) [Q2]

3.44% more ownership

Funds ownership: 75.74% [Q1] → 79.18% (+3.44%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

4% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 47

2% less funds holding

Funds holding: 239 [Q1] → 234 (-5) [Q2]

18% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 90

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $15
• Avg. target: $15.33
• High target: $16

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

UBS Dan Leonard	$15	Buy Maintained	7 Aug 2025
Keybanc Scott Schoenhaus	$15	Overweight Maintained	14 Jul 2025
Morgan Stanley Sean Laaman	$16	Equal-Weight Assumed	3 Jul 2025